BofA lowered the firm’s price target on Acumen (ABOS) to $8 from $9 and keeps a Buy rating on the shares, citing an updated cash position following the company’s Q3 update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABOS: